Brainstorm Health co-chairs open the mainstage conversation by offering their thoughts on the rapidly moving transformations taking place at the nexus of health, science, technology, and business globally—and drill down into how these factors can drive better health outcomes while building business value. 
Dr. David B. Agus, Chief Executive Officer, Ellison Institute for Transformative Medicine; Co-chair, Fortune Brainstorm Health 
Arianna Huffington, Founder and CEO, Thrive; Co-chair, Fortune Brainstorm Health 
Siobhan O’Connor, Media Executive and Journalist; Co-chair, Fortune Brainstorm Health

Brainstorm Health co-chairs open the mainstage conversation by offering their thoughts on the rapidly moving transformations taking place at the nexus of health, science, technology, and business globally—and drill down into how these factors can drive better health outcomes while building business value

SETTING THE STAGE: CONNECTING THE WORLD

The COVID-19 pandemic has exposed just how interconnected we are, and with it, the need for a collaborative global strategy that can transform our approach to health. It’s a new frontier for everything from science to business, creating opportunities for leverage within a new space. A conversation on the need for forward-thinking, universal strategies in health. 
Dr. Albert Bourla, Chairman and CEO, Pfizer 
Interviewer: Dr. David B. Agus, Ellison Institute for Transformative Medicine

The COVID-19 pandemic has exposed just how interconnected we are, and with it, the need for a collaborative global strategy that can transform our approach to health. It’s a new frontier for everything from science to business, creating opportunities for leverage within a new space. A conversation on the need for forward-thinking, universal strategies in health.

LEVERAGING NEW FRONTIERS: THE IMPORTANCE OF A GLOBAL STRATEGY

Venture capital has been pouring into the digital health space for years now, with 2021 notching a record level of investment in the category. Over the past decade, funding for health tech has grown nearly 2,000%, with more than $20 billion invested in all. We hear from leaders in the space about the meteoric growth of the industry—and whether these valuations are truly sustainable. 
Scott Barclay, Managing Director, Insight Partners 
Emily Melton, Founder and Managing Partner, Threshold Ventures 
Deena Shakir, Partner, Lux Capital 
Moderator: Michal Lev-Ram, Editorial Director, Live Media; Editor-at-Large, FORTUNE

Venture capital has been pouring into the digital health space for years now, with 2021 notching a record level of investment in the category. Over the past decade, funding for health tech has grown nearly 2,000%, with more than $20 billion invested in all. We hear from leaders in the space about the meteoric growth of the industry—and whether these valuations are truly sustainable.

THE VC’S VIEW: INVESTING IN HEALTH CARE

The pandemic teleported us into a world of virtual meetings, transforming how we work, how we engage with each other, and how we seek out health care. This telehealth revolution has increased access to quality health care and disrupted dynamics between patients and their physicians. With the global telehealth market projected to grow tenfold, to $560 billion by 2027, the trend is here to stay. What are the challenges—and opportunities—of this monumental shift? 
David Ebersman, Co-founder and CEO, Lyra Health 
Dr. Kristi Henderson, Chief Executive Officer, Optum Everycare 
Kate Ryder, Founder and CEO, Maven 
Moderator: Siobhan O’Connor, Media Executive and Journalist

The pandemic teleported us into a world of virtual meetings, transforming how we work, how we engage with each other, and how we seek out health care. This telehealth revolution has increased access to quality health care and disrupted dynamics between patients and their physicians. With the global telehealth market projected to grow tenfold, to $560 billion by 2027, the trend is here to stay. What are the challenges—and opportunities—of this monumental shift?

LIFE-CHANGING SCREEN TIME IS HERE TO STAY: THE TELEHEALTH REVOLUTION

Burnout-fighter meditation; empowerment to teach to your teams 

		Tara Stiles, Co-founder, Strala Yoga

MINDFULNESS MOMENT

An astonishing 90% of the $3.8 trillion in U.S. health care spending is for people with chronic physical and mental health conditions. But many of these stress-related diseases can be better mitigated or even prevented with early intervention. To curb this chronic crisis, healthcare leaders discuss why we must shift our mindset from treatment to prevention by taking a “first-mile” approach to health and wellbeing. 
Dr. Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization (BIO) 
Dr. Mona Siddiqui, Senior Vice President, Enterprise Clinical Strategy and Quality, Humana 
Nick Stefanizzi, Chief Executive Officer, Northwell Direct 
Moderator: Arianna Huffington, Thrive

An astonishing 90% of the $3.8 trillion in U.S. health care spending is for people with chronic physical and mental health conditions. But many of these stress-related threats can be better mitigated or even prevented with early intervention. To curb this chronic crisis, health care leaders discuss why we must shift our mindset from treatment to prevention by taking a “first-mile” approach to health and well-being.

HOW PREVENTION CAN PREVAIL: THE FIRST-MILE APPROACH

NETWORKING BREAK

The drastic drop in the cost of genomic sequencing has already changed medicine. Now genomic sequencing gets democratized with a portable, cloud-connected device that fits in the palm of your hand. Oxford Nanopore is aiming to make DNA analysis easy, accessible and affordable. Witness a live demonstration of miniaturized genomic sequencing as we hear from the company’s CEO on the power behind this transformational technology and how it’s being utilized around the globe. 
Dr. Gordon Sanghera, Chief Executive Officer, Oxford Nanopore Technologies 
Interviewer: Dr. David B. Agus, Ellison Institute for Transformative Medicine

The drastic drop in the cost of genomic sequencing has already changed medicine. Now genomic sequencing gets democratized with a portable, cloud-connected device that fits in the palm of your hand. Oxford Nanopore is aiming to make DNA analysis easy, accessible and affordable. Witness a live demonstration of miniaturized genomic sequencing as we hear from the company’s CEO on the power behind this transformational technology and how it’s being utilized around the globe.

THE LONG READ: GENE SEQUENCING AND THE CLOUD

Until recently, scientific research into the therapeutic use of psychedelic compounds was severely limited. Now, as restrictions loosen, venture capital for the development of new mental health drugs is flooding the space. A crop of new startups is being founded on the belief that psychedelics could be a powerful antidote to a growing global mental health crisis that has, for some people, resisted traditional approaches. But are we ready for a psychedelic sunrise? 
Florian Brand, Co-founder and CEO, atai Life Sciences 
Neil Markey, Co-founder and CEO, Beckley Retreats 
Dr. Carolyn Rodriguez, Director, Translational Therapeutics Lab, Department of Psychiatry, Stanford University School of Medicine 
Moderator: Siobhan O’Connor, Media Executive and Journalist

Until recently, scientific research into the therapeutic use of psychedelic compounds was severely limited. Now, as restrictions loosen, venture capital for the development of new mental health drugs is flooding the space. A crop of new startups is being founded on the belief that psychedelics could be a powerful antidote to a growing global mental health crisis that has, for some people, resisted traditional approaches. But are we ready for a psychedelic sunrise?

BUSINESS TRIP: THE BOOMING AGE OF PSYCHEDELICS IN HEALTH CARE

The convergence of biotech, medtech, and information technology is fueling a century-defining life sciences revolution, generating medical advances at a pace never witnessed before. But new research models and incentives will be needed to bring together great minds across disparate disciplines. An early look at a future is taking shape in Silicon Valley, where life science moonshots are fast becoming one of the region’s hottest new spaces. 
Patrick Collison, Co-founder, Arc Institute; Co-founder and CEO, Stripe 
Interviewer: Dr. Lloyd Minor, Carl and Elizabeth Naumann Dean, Stanford University School of Medicine

The convergence of biotech, medtech, and information technology is fueling a century-defining life sciences revolution, generating medical advances at a pace never witnessed before. But new research models and incentives will be needed to bring together great minds across disparate disciplines. An early look at a future is taking shape in Silicon Valley, where life science moonshots are fast becoming one of the region’s hottest new spaces.

IS A LIFE SCIENCES REVOLUTION SILICON VALLEY’S NEXT ACT?

The pandemic has shown that the fields of science, medicine, and healthcare can be innovative and resilient. The speedy global response has also resulted in massive amounts of valuable data that can be harnessed to build even stronger, results-driven systems. Hear a conversation on the future of data, the benefits agility and speed, and how reinventing processes can optimize organizational performance, build value and drive better care. 
Hilary Kerner, Chief Marketing Officer, IBM Watson Health 
Lynn O’Connor Vos, Board Director, Former CEO, Modular Medical 
Moderator: Michal Lev-Ram, FORTUNE

The pandemic has shown that the fields of science, medicine, and healthcare can be innovative and resilient. The speedy global response has also resulted in massive amounts of valuable data that can be harnessed to build even stronger, results-driven systems. Hear a conversation on the future of data, the benefits agility and speed, and how reinventing processes can optimize organizational performance, build value and drive better care.

FROM CHALLENGE COMES CHANGE: THE FUTURE OF DATA, AI, AND HEALTH

Climate change is already influencing human health. Existing threats are intensifying, new threats are emerging, and who will suffer most varies unequally with age, wealth, and location. Globally, disruptions to physical, biological, and ecological systems are impacting public health, leading to increased respiratory and cardiovascular disease, injuries and premature deaths related to extreme weather events, and even threats to mental health. Global leaders and grassroots efforts alike will be needed to overcome these existential challenges. 
Dr. Renee Salas, Yerby Fellow, Center for Climate, Health, and the Global Environment, Harvard T.H. Chan School of Public Health 
Moderator: Beth Kowitt, Senior Editor, FORTUNE

Climate change is already influencing human health. Existing threats are intensifying, new threats are emerging, and who will suffer most varies unequally with age, wealth, and location. Globally, disruptions to physical, biological, and ecological systems are impacting public health, leading to increased respiratory and cardiovascular disease, injuries and premature deaths related to extreme weather events, and even threats to mental health. Global leaders and grassroots efforts alike will be needed to overcome these existential challenges.

A TALE OF TWO CRISES: THE IMPACTS OF CLIMATE CHANGE AND GLOBAL HEALTH

People are an organization's most valuable asset. Now more than ever it’s clear that keeping worker and customer well-being central offers a strategic advantage. From employee productivity and retention to customer experience and connection, we’ll talk with executives who know first-hand the importance of focusing on the human factor for the good of their people, their customers and their business. 
Fran Katsoudas, Executive Vice President and Chief People, Policy and Purpose Officer, Cisco 
Dr. Henry Ting, Senior Vice President and Chief Health Officer, Delta Air Lines 
Tara Mahoney, Global Healthcare Managing Director, Genesys 

Moderator: Arianna Huffington, Thrive

An organization's most valuable asset is its people. Now more than ever it’s clear that keeping worker wellness core offers a strategic advantage. From productivity to recruitment to employee retention, we’ll talk with executives who know the importance of focusing on the human factor for the good of their people and for keeping a competitive edge

PEOPLE-CENTERED BUSINESS STRATEGIES: WHY WELL BEING IS MISSION-CRITICAL

WELCOME RECEPTION

THE SINGING SURGEONS REUNITE 
During the peak of the pandemic, these two talented surgeons captivated the world with their inspiring musical rendition of John Lennon’s “Imagine”. Let’s look at how life has changed since their hopeful message went viral—and how it feels to come full circle from the inside of a pandemic. 
Dr. Elvis Francois, Orthopedic Spine Surgeon, Resurgens Orthopedics 
Dr. William Robinson, Orthopedic Spine Surgeon, W.B. Carrell Clinic 
Moderator: Michal Lev-Ram, FORTUNE 

FORTUNE BRAINSTORM HEALTH BERNARD J. TYSON MEMORIAL AWARD 
Fortune Brainstorm Health will bestow the 2022 “Bernard J. Tyson Memorial Award” posthumously to world-renowned global health champion Dr. Paul Farmer of Partners in Health. We are honored to be joined by Didi Bertrand Farmer to accept the award on behalf of her late husband. 
Presented by: Denise Bradley-Tyson, Founder and CEO, Inspired Luxe 
Dr. Paul Farmer, posthumously 
Accepting Award: Didi Bertrand Farmer, Senior Adviser, Partners in Health; Co-founder and President, The Women and Girls Initiative 
Introduction: Clifton Leaf, Former FORTUNE Editor-in-Chief and Founder, Fortune Brainstorm Health

FORTUNE BRAINSTORM HEALTH BERNARD J. TYSON MEMORIAL AWARD 
Fortune Brainstorm Health will bestow the 2022 “Bernard J. Tyson Memorial Award” posthumously to world-renowned global health champion Dr. Paul Farmer of Partners in Health. We are honored to be joined by Didi Bertrand Farmer to accept the award on behalf of her late husband.
THE SINGING SURGEONS REUNITE 
During the peak of the pandemic, these two talented surgeons captivated the world with their inspiring musical rendition of John Lennon’s Imagine. Let’s look at how life has changed since their hopeful message went viral — and how it feels to come full circle from the inside of a pandemic

DINNER AND PROGRAM

Up to half of U.S. nurses and physicians were feeling burned out before the pandemic. Then, amid the most grueling working conditions of their careers, their hospitals cut salaries, reduced benefits, and canceled raises, forcing staffers to work more shifts with longer hours and diminished paid time off. With estimates that the health care sector has lost nearly half a million workers since February 2020, what measures can be taken to retain the health care workforce of the present—and train the workforce of the future? 
Dr. Georges Benjamin, Executive Director, American Public Health Association 
Lynda Benton, Senior Director, Global Community Impact, Johnson & Johnson 
Vivek Sharma, Chief Executive Officer, InStride 
Qualenta Kivett, Executive Vice President, Chief People and Talent Officer, Tampa General Hospital 
Moderator: Clifton Leaf, Former FORTUNE Editor-in-Chief and Founder, Fortune Brainstorm Health

Up to half of U.S. nurses and physicians were feeling burned out before the pandemic. Then, amid the most grueling working conditions of their careers, their hospitals cut salaries, reduced benefits, and canceled raises, forcing staffers to work more shifts with longer hours and diminished paid time off. With estimates that the health care sector has lost nearly half a million workers since February 2020, what measures can be taken to retain the health care workforce of the present—and train the workforce of the future?

CONCURRENT BREAKFAST SESSION: BUILDING THE HEALTH CARE WORKFORCE OF THE FUTURE

Hosted by Bristol Myers Squibb 
Broad hurdles exist for underserved populations around the world, exacerbating issues of access and equity. We’ll delve into how clinical trial diversity, better representation across STEM and product innovation can lead to breakthrough solutions that can positively impact health outcomes across many disparate demographics. 
Dr. Michelle McMurry-Heath, President and CEO, Biotechnology Innovation Organization (BIO) 
Sylvana Q. Sinha, Founder and CEO, Praava Health 
Winselow Tucker, Senior Vice President, Intercontinental, Bristol Myers Squibb 
Moderator: Michal Lev-Ram, FORTUNE

Hosted by Bristol Myers Squibb 
Broad hurdles exist for underserved populations around the world, exacerbating issues of access and equity. We’ll delve into how clinical trial diversity, better representation across STEM and product innovation can lead to breakthrough solutions that can positively impact health outcomes across many disparate demographics.

CONCURRENT BREAKFAST SESSION: LEVELING THE PLAYING FIELD-TRANSFORMING PATIENT ACCESS AND EQUITY

Research and studies show that the benefits of practicing mindfulness in the workplace are abundant. From an increase in emotional intelligence, to improved communication, to its contributions to better physical health and reduced interpersonal conflicts, the payoffs of improving mindfulness are clear. But how can corporations effectively integrate the practice into their workforces? We hear from experts who have done just that, and whose organizations are experiencing the rewards. 
Maria Dee, Executive Director, Workforce Wellbeing, Kaiser Permanente 
Tara Stiles, Co-founder, Strala Yoga 
Dr. Aaliya Yaqub, Chief Medical Officer, Thrive 
Moderator: Siobhan O’Connor, Media Executive and Journalist

Research and studies show that the benefits of practicing mindfulness in the workplace are abundant. From an increase in emotional intelligence, to improved communication, to its contributions to better physical health and reduced interpersonal conflicts, the payoffs of improving mindfulness are clear. But how can corporations effectively integrate the practice into their workforces? We hear from experts who have done just that, and whose organizations are experiencing the rewards.

CONCURRENT BREAKFAST SESSION: BUILDING A MORE RESILIENT ORGANIZATION

SWITCH BREAK

WELCOME BACK

From deadly pathogens to war-induced humanitarian crises and the effects of climate disasters, the toll of health challenges can seem insurmountable. But global threats can only be met with a global response. A conversation on the need, benefits, and challenges of forming a global governing body dedicated to establishing uniform policies on health. 
Sir Tony Blair, Executive Chairman, Tony Blair Institute for Global Change 
Interviewer: Dr. David B. Agus, Ellison Institute for Transformative Medicine

From deadly pathogens to war-induced humanitarian crises and the effects of climate disasters, the toll of health challenges can seem insurmountable. But global threats can only be met with a global response. A conversation on the need, benefits, and challenges of forming a global governing body dedicated to establishing uniform policies on health.

THE INTERNATIONAL IMPERATIVE: WORLDWIDE HEALTH GOVERNANCE

In a hyperconnected world rife with virulent pathogens, preparedness is our best defense. After ebola roared through West Africa and the novel coronavirus brought the world to its knees, the most pressing question for the safety of the global population is this: What have we learned—and how can we better prepare for the next hypercontagious disease? 
Dr. Sandro Galea, Dean and Robert A. Knox Professor, Boston University School of Public Health 
Dr. Angela Rasmussen, Virologist, Department of Vaccine and Infectious Disease, University of Saskatchewan 
Moderator: Clifton Leaf, Former FORTUNE Editor-in-Chief and Founder, Fortune Brainstorm Health

In a hyperconnected world rife with virulent pathogens, preparedness is our best defense. After ebola roared through West Africa and the novel coronavirus brought the world to its knees, the most pressing question for the safety of the global population is this: What have we learned—and how can we better prepare for the next hypercontagious disease?

EXISTENTIAL THREATS: PREPARING FOR THE NEXT GLOBAL HEALTH CRISIS

New forward-looking business models are breaking economic, social, and racial boundaries, offering more equitable access to therapeutics and benefiting people who are often overlooked and underserved in healthcare. Hear what leading organizations are doing to close the health-equity gap—and learn about the biggest obstacles that still need to be removed. 
Eren Bali, Co-founder and CEO, Carbon Health 
Dr. Marlow Hernandez, Chief Executive Officer, Cano Health 
Dr. Alex Oshmyansky, Founder and CEO, Mark Cuban Cost Plus Drug Company 
Moderator: Beth Kowitt, FORTUNE

New forward-looking business models are breaking economic, social, and racial boundaries, offering more equitable access to therapeutics and benefiting people who are often overlooked and underserved in healthcare. Hear what leading organizations are doing to close the health-equity gap—and learn about the biggest obstacles that still need to be removed.

ACCELERATING HEALTH EQUITY BY CHALLENGING THE STATUS QUO

How do we get people back to the office, even part-time? The world of work continues to undergo a massive overhaul. After two years of working remotely, employees sense that the office is beckoning—but their demands for WFH are just as insistent. How can business leaders leverage this moment to develop smarter, safer, and healthier workspaces for their employees? And what can we learn from design thinking to make these spaces ripe for innovation? 
Dr. Pamela Hymel, Chief Medical Officer, Disney Parks, Experiences and Products 
Dr. Bon Ku, Director, Health Design Lab, Thomas Jefferson University 
Dr. Fatima Paruk, Senior Vice President and Chief Health Officer, Salesforce 
Moderator: Phil Wahba, Senior Writer, FORTUNE

How do we get people back to the office, even part-time? The world of work continues to undergo a massive overhaul. After two years of working remotely, employees sense that the office is beckoning—but their demands for WFH are just as insistent. How can business leaders leverage this moment to develop smarter, safer, and healthier workspaces for their employees? And what can we learn from design thinking to make these spaces ripe for innovation?

BRICKS, MORTAR AND BETTER HEALTH: WORKSPACES REDESIGNED

Imagine healthcare software systems — which are notoriously clunky and non-interoperable — capable of seamlessly sharing information, verifying patient consent, even providing records of things like vaccine status, all in a privacy-protecting and tamper-proof manner. That is one of the big promises of blockchain for healthcare, a growing area of investment and inquiry that has the potential to provide more security for patients and tamp down global healthcare costs to the tune of tens of billions of dollars per year. Hear from leaders at the leading edge about the possibilities — and the challenges — of this crypto-powered movement. 
Gabriela Pelin, Chief Innovation Officer, Avaneer Healthcare 
Eric Piscini, Global Vice President, Emerging Business Networks, IBM Watson Health 
	Moderator: Siobhan O’Connor, Media Executive and Journalist

Imagine healthcare software systems — which are notoriously clunky and non-interoperable — capable of seamlessly sharing information, verifying patient consent, even providing records of things like vaccine status, all in a privacy-protecting and tamper-proof manner. That is one of the big promises of blockchain for healthcare, a growing area of investment and inquiry that has the potential to provide more security for patients and tamp down global healthcare costs to the tune of tens of billions of dollars per year. Hear from leaders at the leading edge about the possibilities — and the challenges — of this crypto-powered movement.

IS BLOCKCHAIN REVIVING HEALTH CARE’S CAPABILITIES?

Burnout-related issues account for nearly $190 billion in annual U.S. health care costs, with stress affecting both chronic diseases and mental health. And burnout and stress have a direct impact on business metrics like productivity, turnover, and the loss of treasured talent — as well as the cost to replace them. Learn from leaders of two major companies about how they're facing these issues head-on. 
Payal Sahni Becher, Executive Vice President and Chief People Experience Officer, Pfizer 
Ty Breland, Executive Vice President and Chief Human Resources Officer, Marriott International 
Moderator: Arianna Huffington, Thrive

Burnout-related issues account for nearly $190 billion in annual U.S. health care costs, with stress alone accounting for 8% of national health care spend. But the deeper cost to business is low productivity, high turnover, and the loss of treasured talent—as well as the cost to replace these workers. Learn from leaders about how companies are facing this issue head-on.

BURNED OUT: TACKLING WELL-BEING AND MENTAL RESILIENCE IN THE WORKPLACE

It takes true grit to operate an airline in today’s environment - soaring fuel prices, inflation, concerns for passenger and employee safety and calls for sustainability initiatives on the heels of historic losses due to the global pandemic are all significant realities to contend with. Yet despite it all, travel demand is roaring back, recently allowing Delta to experience record breaking bookings. What the future holds for the world’s largest airline. 
Ed Bastian, Chief Executive Officer, Delta Air Lines 
Interviewer: Alan Murray, Chief Executive Officer, FORTUNE

It takes true grit to operate an airline in today’s environment - soaring fuel prices, inflation, concerns for passenger and employee safety and calls for sustainability initiatives on the heels of historic losses due to the global pandemic are all significant realities to contend with. Yet despite it all, travel demand is roaring back, recently allowing Delta to experience record breaking bookings. What the future holds for the world’s largest airline.

BACK TO THE FUTURE: ONE ON ONE WITH DELTA’S CEO

A world-leading contributor to the field of brain development, brain plasticity, and neural regeneration and repair, gives insights on future innovations and the ability of our nervous systems to rewire and learn new behaviors, skills and cognitive functioning. 
Dr. Andrew Huberman, Professor, Department of Neurobiology, Stanford University School of Medicine; Host, The Huberman Lab Podcast

A world-leading contributor to the field of brain development, brain plasticity, and neural regeneration and repair, gives insights on future innovations and the ability of our nervous systems to rewire and learn new behaviors, skills and cognitive functioning.

IMBEDDED INTELLIGENCE

Breast cancer is the second most common cancer diagnosis among women in the U.S., and early detection is key. Enter iBreastExam—an FDA-cleared, hand-held breast examination device that patients and doctors can use for routine clinical exams between scheduled mammograms. It’s a battery-powered, radiation-free early detection device that has been used in checkups for over 500,000 women in 10 countries, and a new distribution deal could mainstream it in the U.S. Will iBreastExam change the game? 
Mihir Shah, Founder and President, UE LifeSciences 
 Interviewer: Beth Kowitt, FORTUNE

Breast cancer is the second most common cancer diagnosis among women in the U.S., and early detection is key. Enter iBreastExam—an FDA-cleared, hand-held breast examination device that patients and doctors can use for routine clinical exams between scheduled mammograms. It’s a battery-powered, radiation-free early detection device that has been used in checkups for over 500,000 women in 10 countries, and a new distribution deal could mainstream it in the U.S. Will iBreastExam change the game?

IN THE PALM OF YOUR HAND: INNOVATIONS IN WOMEN’S DIAGNOSTICS

The pandemic exposed gaps in America’s health care system, led to a surge in demand, and revealed opportunities for businesses to innovate and scale. A global health services company leader shares how society can build a more sustainable, accessible health care system that provides affordable, predictable, and simplified care while building business value. 
 
David Cordani, Chairman and CEO, Cigna 
 Interviewer: Arianna Huffington, Thrive

The pandemic exposed gaps in America’s health care system, led to a surge in demand, and revealed opportunities for businesses to innovate and scale. A global health services company leader shares how society can build a more sustainable, accessible health care system that provides affordable, predictable, and simplified care while building business value.

CONNECTED HEALTH FOR ALL: INVESTING IN ACCESS AND IMPROVED OUTCOMES

It’s a new baby boom (of sorts): The business of fertility treatments is soaring globally, with analysts expecting the market to reach $22 billion by 2025. In 2021, nearly $200 million worth of venture capital poured into fertility startups. As treatments become more common, a growing number of companies are offering extensive fertility benefits to attract and retain high performers. With the costs of fertility treatment still untenably high for many people, what’s at stake for companies that do—or don’t—offer these benefits at scale? 
TJ Farnsworth, Founder and CEO, Inception Fertility 
Tammy Sun, Co-founder and CEO, Carrot Fertility 
Moderator: Siobhan O’Connor, Media Executive and Journalist

It’s a new baby boom (of sorts): The business of fertility treatments is soaring globally, with analysts expecting the market to reach $22 billion by 2025. In 2021, nearly $200 million worth of venture capital poured into fertility startups. As treatments become more common, a growing number of companies are offering extensive fertility benefits to attract and retain high performers. With the costs of fertility treatment still untenably high for many people, what’s at stake for companies that do—or don’t—offer these benefits at scale?

FERTILITY BENEFITS: THE NEW FRONTLINE IN EMPLOYEE RETENTION

Artificial intelligence is delivering rapid innovation in science and medicine, transforming traditional health care business models. The use of A.I.-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of personalized, affordable therapeutics that are as efficient as it is scalable. Here, a conversation on innovation in A.I., and how leaders are breaking barriers to treatment. 
Dean Bitan, Co-founder and CEO, Imagene AI 
Interviewer: Bryan Walsh, Editor, Future Perfect, VOX

Artificial intelligence is delivering rapid innovation in science and medicine, transforming traditional health care business models. The use of A.I.-based molecular testing in cancer diagnostics is revolutionizing patient care by offering a new level of personalized, affordable therapeutics that are as efficient as it is scalable. Here, a conversation on innovation in A.I., and how leaders are breaking barriers to treatment.

THE POWER OF AI: REVOLUTIONIZING AND DEMOCRATIZING CANCER DIAGNOSIS

Thanks to technological advances in artificial intelligence and digital sensors, devices that deliver biometric data are becoming big business in health. Market analysts estimate more than 300 million wearables will ship globally in 2022 alone. Innovations have led to sensors that can measure everything from blood glucose and alcohol levels to resting heart rate, ketones, and more. Digital devices put health tracking in the hands of millions and can motivate positive health habits. But some doctors and privacy advocates are skeptical. What’s next for the category? 
Adrian Aoun, Founder and CEO, Forward 
Jennifer Ernst, Co-founder and CEO, Tivic Health 
Robert Ford, Chairman and CEO, Abbott 
Moderator: Phil Wahba, FORTUNE

Thanks to technological advances in artificial intelligence and digital sensors, devices that deliver biometric data are becoming big business in health. Market analysts estimate more than 300 million wearables will ship globally in 2022 alone. Innovations have led to sensors that can measure everything from blood glucose and alcohol levels to resting heart rate, ketones, and more. Digital devices put health tracking in the hands of millions and can motivate positive health habits. But some doctors and privacy advocates are skeptical. What’s next for the category?

DRIVING DIGITAL HEALTH: WHERE WEARABLES ARE HEADED NEXT

Hosted by Bristol Myers Squibb 
Development of therapeutics can be a lengthy, complex, and costly process, entrenched with a high degree of uncertainty for successful outcomes. But next gen therapies for diseases affecting global populations are accelerating. A look at the factors behind the increasing rate of scientific innovation at all stages of drug development. 
Dr. Harold Bernstein, Senior Vice President, Chief Medical Officer and Head of Global Clinical Development, BioMarin 
Dr. Samit Hirawat, Executive Vice President and Chief Medical Officer, Bristol Myers Squibb 
Dr. Sanjiv Patel, President and CEO, Relay Therapeutics 
Moderator: Siobhan O’Connor,, Media Executive and Journalist

Hosted by Bristol Myers Squibb 
Development of therapeutics can be a lengthy, complex, and costly process, entrenched with a high degree of uncertainty for successful outcomes. But next gen therapies for diseases affecting global populations are accelerating. A look at the factors behind the increasing rate of scientific innovation at all stages of drug development.

CONCURRENT LUNCH: ACCELERATING SCIENTIFIC BREAKTHROUGHS-THE POWER OF NEXT GEN THERAPIES

Hosted by IBM Watson Health 
Healthcare has an abundance of data, but the value remains largely untapped. Traditionally, healthcare organizations have held their data close to the vest – to maintain security, privacy and competitive advantage. But in a connected world that is ready to re-imagine a new path forward for healthcare, this approach will fall short. People are not just patients in a single health system – they could have multiple care providers, be members of a health insurance plan, be citizens who need social program services, or could be participants in a clinical trial. Data collaboration will enable organizations to get a holistic view of each person they serve, through Intelligent Health Records, and help them derive more value in healthcare’s next chapter. 
Dr. Cecil Lynch, Chief Medical Information Officer, Accenture 
Sylvana Q. Sinha, Founder and CEO, Praava Health 
Dr. David Stark, Chief Medical Officer, Head of HR Data, Analytics and Technology Strategy, Morgan Stanley 
Amy Wykoff, Vice President, Product Management, IBM Watson Health 
Moderator: Clifton Leaf, Former FORTUNE Editor-in-Chief and Founder, Fortune Brainstorm Health

Hosted by IBM Watson Health 
Healthcare has an abundance of data, but the value remains largely untapped. Traditionally, healthcare organizations have held their data close to the vest – to maintain security, privacy and competitive advantage. But in a connected world that is ready to re-imagine a new path forward for healthcare, this approach will fall short. People are not just patients in a single health system – they could have multiple care providers, be members of a health insurance plan, be citizens who need social program services, or could be participants in a clinical trial. Data collaboration will enable organizations to get a holistic view of each person they serve, through Intelligent Health Records, and help them derive more value in healthcare’s next chapter.

CONCURRENT LUNCH: INTELLIGENT HEALTH RECORDS-HOW DATA COLLABORATION WILL REVOLUTIONIZE HEALTHCARE

Hosted by Salesforce 
The post-pandemic era will usher in a new landscape for the delivery of health care from the consumer perspective. Expectations and preferences have evolved in terms of telehealth and virtual health services from anywhere via an end-to-end seamless experience. How will data-driven preparedness facilitate the imperatives of high-value, equitable, virtual health care to meet consumer demands and what challenges will need to be addressed? 
Ron Emerson, Global Healthcare Lead, Zoom Video Communications 
Diana Gelston, Vice President, Virtual Care Sales, Marketing, and Client Success, Best Buy Health 
Dr. Fatima Paruk, Senior Vice President and Chief Health Officer, Salesforce 
Moderator: Alan Murray, FORTUNE

Hosted by Salesforce 
The post-pandemic era will usher in a new landscape for the delivery of health care from the consumer perspective. Expectations and preferences have evolved in terms of telehealth and virtual health services from anywhere via an end-to-end seamless experience. How will data-driven preparedness facilitate the imperatives of high-value, equitable, virtual health care to meet consumer demands and what challenges will need to be addressed?

CONCURRENT LUNCH: CHANGING HEALTH CONSUMER EXPECTATIONS-CHALLENGES, OPPORTUNITIES AND IMPERATIVES

Recent studies indicate that the current generation of children is falling behind on their social, emotional, and communication skills, a fact partially attributed to excess screen time and social media. Moxie, an A.I.-based emotional support robot, is built to foster social, cognitive, and emotional development in children, and is especially effective for those with developmental issues, including autism. Moxie is made for these kids. Let’s meet Moxie! 
Paolo Pirjanian, Founder and CEO, Embodied 
Interviewer: Siobhan O’Connor, Media Executive and Journalist

Recent studies indicate that the current generation of children is falling behind on their social, emotional, and communication skills, a fact partially attributed to excess screen time and social media. Moxie, an A.I.-based emotional support robot, is built to foster social, cognitive, and emotional development in children, and is especially effective for those with developmental issues, including autism. Moxie is made for these kids. Let’s meet Moxie!

ROBOT BESTIES: RETHINKING HUMAN–MACHINE INTERACTIONS WITH MOXIE

The potential of big data in healthcare relies on detecting patterns and turning high volumes of information into actionable knowledge for precision medicine and improvement of patient outcomes. Learn how data can be better accessed and synthesized, how patient data gaps can be closed, and how companies are overcoming the challenge of data analytics innovation. 
Nancy Brown, Chief Executive Officer, American Heart Association 
David Hodgson, Co-founder and CEO, Project Ronin 
Dr. Jessica Mega, Co-founder, Chief Medical and Scientific Officer, Verily 
Moderator: Michal Lev-Ram, FORTUNE

The potential of big data in healthcare relies on detecting patterns and turning high volumes of information into actionable knowledge for precision medicine and improvement of patient outcomes. Learn how data can be better accessed and synthesized, how patient data gaps can be closed, and how companies are overcoming the challenge of data analytics innovation.

BIG DATA IN HEALTH CARE: PROMISES, PERILS, AND PRECISION MEDICINE

The field of women’s health is at a critical junction. On the one hand, innovations in consumer tech and new research initiatives are opening the door to new solutions, insightful data, and more access. On the other hand, new restrictions on reproductive rights, coupled with privacy concerns, are presenting new challenges. We hear from two experts on what this new era holds for women’s health. 
Dr. Sumbul Ahmad Desai, Vice President, Health, Apple 
Dr. Paula Johnson, President, Wellesley College 
Dr. Michelle Williams, Dean of the Faculty, T.H. Chan School of Public Health, Harvard University 
Moderator: Arianna Huffington, Thrive

The last two years have taken a disproportionate toll on women’s mental health, their economic outcomes, and their access to essential health care. The pandemic resulted in more than 2 million women leaving the workforce, and many have not returned. Hear from leaders on how research and public policy can inform decisions to support and empower women now—and for future generations.

A NEW ERA FOR WOMEN’S HEALTH

Take-home tools from Brainstorm Health to use at your desk, on the road or anywhere. 
Tara Stiles, Co-founder, Strala Yoga

The World Health Organization defines an infodemic as the spread of “false or misleading information in digital and physical environments during a disease outbreak.” Effective and equitable responses to these new challenges require research investment to provide policy-relevant evidence—and novel approaches to reaching vulnerable communities. Here, we hear from leaders about the task of separating fact from fiction. 
Dr. Georges Benjamin, Executive Director, American Public Health Association 
Dr. Jesse Ehrenfeld, Former Chair, Board of Trustees, American Medical Association 
Moderator: Phil Wahba, FORTUNE

The World Health Organization defines an infodemic as the spread of “false or misleading information in digital and physical environments during a disease outbreak.” Effective and equitable responses to these new challenges require research investment to provide policy-relevant evidence—and novel approaches to reaching vulnerable communities. Here, we hear from leaders about the task of separating fact from fiction.

INFODEMICS: HOW TO COUNTER THE HEALTH CARE MISINFORMATION EFFECT

CVS Health is one of the largest health solutions providers in the United States and has been on the frontlines of the pandemic, administering COVID-19 tests and vaccines and addressing the increased need for mental health services. The company operates nearly 10,000 retail locations across the U.S. and is seeing an increase in virtual visits through its digital channels. A conversation with CVS Health’s CEO on keeping consumers in focus and how the health solutions business is evolving. 
Karen S. Lynch, President and CEO CVS Health 
Interviewer: Alan Murray, FORTUNE

CVS Health is one of the largest health solutions providers in the United States and has been on the frontlines of the pandemic, administering COVID-19 tests and vaccines and addressing the increased need for mental health services. The company operates nearly 10,000 retail locations across the U.S. and is seeing an increase in virtual visits through its digital channels. A conversation with CVS Health’s CEO on keeping consumers in focus and how the health solutions business is evolving.

THE CHANGING LANDSCAPE OF HEALTH SOLUTIONS

Artificial intelligence and machine learning are playing a key role in patient diagnostics and therapeutics. But the true value of innovative data sequencing and predictive algorithms is the real-life impact they have on people. A conversation with a leader in the space on how technology is providing truly personalized pathways in health. 
Eric Lefkofsky, Founder and CEO, Tempus 
Interviewer: Dr. David B. Agus, Ellison Institute for Transformative Medicine

Artificial intelligence and machine learning are playing a key role in patient diagnostics and therapeutics. But the true value of innovative data sequencing and predictive algorithms is the real-life impact they have on people. A conversation with a leader in the space on how technology is providing truly personalized pathways in health.

PATIENTS FIRST: TRANSFORMING CARE THROUGH DISRUPTIVE TECHNOLOGY

The value and power of sleep is often underrated. Sleep can lead to a more productive, joyful and inspired life. A lack of quality sleep can have the opposite effects, including an increased risk of health issues, poor work performance and problems with mood and relationships. Enter John Legend, who wants to make sure we all get quality Z’s. The award winning singer, songwriter, and producer joins us for a conversation about the importance of sleep and his sleepcast series on the Headspace app. 
Russ Glass, Chief Executive Officer, Headspace Health 
John Legend, Multiplatinum Recording Artist, EGOT Recipient, and Philanthropist 
Moderator: Arianna Huffington, Thrive

This meditation app teamed up with John Legend to bring you their newest sleepcast: a bedtime story narrated by the Legend himself.

SELF-CARE STARTS WITH LEGENDARY SLEEP

CLOSING RECEPTION

<h3 id="brainstorm-health-connecting-the-world"><meta charset="utf-8">BRAINSTORM HEALTH: CONNECTING THE WORLD</h3>



 <meta charset="utf-8">The seventh annual Brainstorm Health conference will gather in person May 10-11, 2022. Brainstorm Health brings together forward-thinking and insightful leaders in health care, technology, and business to leverage the rapid growth across these sectors and explore ways to drive meaningful change worldwide. As the fields of science and medicine continue to innovate, it’s clear health and&nbsp;health care&nbsp;are global in nature — and interconnected.&nbsp;The program will look at how new technologies,&nbsp;worldwide&nbsp;collaboration,&nbsp;evolving&nbsp;therapeutics, and big data drive better health outcomes and business value.



&nbsp;We’ll hear from experts about investing in health care; look at the urgency of a global business strategy to remain resilient; and talk about what lies ahead in the battle with COVID-19. As we talk to business leaders about best practices for navigating the ever-changing pandemic landscape, we’ll continue the conversations on crucial issues such as upstream preventive interventions, the global mental health crisis, and the need to eradicate racial inequities so&nbsp;health care is accessible for all.&nbsp;As always, we have a few surprises in store, and plenty of opportunities to engage with other leaders. Please join us for these vital discussions. 



Confirmed participants include CEOs Dr. Albert Bourla of Pfizer, Dean Bitan of Imagene AI,&nbsp;Patrick Collison of Stripe, David Cordani of Cigna, Eric Lefkofsky of Tempus Labs and Dr. Alex Oshmyansky of Mark Cuban Cost Plus Drug Company, as well as Apple Vice President of Health Dr. Sumbul Ahmad Desai, Lux Capital Partner Deena Shakir, and Harvard’s T.H. Chan School of Public Health Dean Michelle Williams.



<meta charset="utf-8">FORTUNE is following guidance issued by local authorities and the CDC and is taking several additional steps to prioritize participants&#8217; health and safety.&nbsp;For&nbsp;Brainstorm Health, all attendees must be &#8220;Up to Date&#8221; with COVID-19 vaccinations.&nbsp;The CDC defines &#8220;<a rel="noreferrer noopener" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_coronavirus_2019-2Dncov_vaccines_stay-2Dup-2Dto-2Ddate.html&amp;d=DwMFaQ&amp;c=HewDBbpecYK86KWBb8Fx0DnzxvObmqf6JAhppYEfnqk&amp;r=fXtlqKoFMPH8BEmgo44GULB-Np4fdjnHiYeVS0t1RrvoyCPiOw1ENvUjbQ6fhG5R&amp;m=YsuQss-s0ymljUO_HbLAEd6Mxj3heXCV1D1jroPFQXXTf4B231xDRP7XTuBMDI8U&amp;s=T-xth_ct0uienKuzBbaltXB2a337KMNgVr_ky20JQwk&amp;e=" target="_blank">Up to Date</a>&#8221; as having received all recommended doses in the primary series COVID-19 vaccine, and a&nbsp;<a rel="noreferrer noopener" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_coronavirus_2019-2Dncov_vaccines_booster-2Dshot.html&amp;d=DwMFaQ&amp;c=HewDBbpecYK86KWBb8Fx0DnzxvObmqf6JAhppYEfnqk&amp;r=fXtlqKoFMPH8BEmgo44GULB-Np4fdjnHiYeVS0t1RrvoyCPiOw1ENvUjbQ6fhG5R&amp;m=YsuQss-s0ymljUO_HbLAEd6Mxj3heXCV1D1jroPFQXXTf4B231xDRP7XTuBMDI8U&amp;s=e-zs3l_0zxmRB8Sh4HC9t_UTnIMMa5ppPMf6IMZ7-vY&amp;e=" target="_blank">booster dose</a>&nbsp;when eligible.* In addition, participants must have a negative result from a PCR test taken up to 48 hours prior to arrival at event registration.&nbsp;All participants will show proof of &#8220;Up to Date&#8221; vaccination status and the negative PCR test before receiving event credentials. Mask&nbsp;protocols will be shared prior to the event and will be based on local guidelines.



*Those who have not received their booster dose will be tested on-site daily.&nbsp;

<h3 id="brainstorm-health-connecting-the-world"><meta charset="utf-8">BRAINSTORM HEALTH: CONNECTING THE WORLD</h3>



 <meta charset="utf-8">The seventh annual Brainstorm Health conference will gather in person May 10-11, 2022. Brainstorm Health brings together forward-thinking and insightful leaders in health care, technology, and business to leverage the rapid growth across these sectors and explore ways to drive meaningful change worldwide. As the fields of science and medicine continue to innovate, it’s clear health and&nbsp;health care&nbsp;are global in nature — and interconnected.&nbsp;The program will look at how new technologies,&nbsp;worldwide&nbsp;collaboration,&nbsp;evolving&nbsp;therapeutics, and big data drive better health outcomes and business value.



&nbsp;We’ll hear from experts about investing in health care; look at the urgency of a global business strategy to remain resilient; and talk about what lies ahead in the battle with COVID-19. As we talk to business leaders about best practices for navigating the ever-changing pandemic landscape, we’ll continue the conversations on crucial issues such as upstream preventive interventions, the global mental health crisis, and the need to eradicate racial inequities so&nbsp;health care is accessible for all.&nbsp;As always, we have a few surprises in store, and plenty of opportunities to engage with other leaders. Please join us for these vital discussions. 



Confirmed participants include CEOs Dr. Albert Bourla of Pfizer, Dean Bitan of Imagene AI,&nbsp;Patrick Collison of Stripe, David Cordani of Cigna, Eric Lefkofsky of Tempus Labs and Dr. Alex Oshmyansky of Mark Cuban Cost Plus Drug Company, as well as Apple Vice President of Health Dr. Sumbul Ahmad Desai, Lux Capital Partner Deena Shakir, and Harvard’s T.H. Chan School of Public Health Dean Michelle Williams.



<meta charset="utf-8">FORTUNE is following guidance issued by local authorities and the CDC and is taking several additional steps to prioritize participants' health and safety.&nbsp;For&nbsp;Brainstorm Health, all attendees must be "Up to Date" with COVID-19 vaccinations.&nbsp;The CDC defines "<a rel="noreferrer noopener" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_coronavirus_2019-2Dncov_vaccines_stay-2Dup-2Dto-2Ddate.html&amp;d=DwMFaQ&amp;c=HewDBbpecYK86KWBb8Fx0DnzxvObmqf6JAhppYEfnqk&amp;r=fXtlqKoFMPH8BEmgo44GULB-Np4fdjnHiYeVS0t1RrvoyCPiOw1ENvUjbQ6fhG5R&amp;m=YsuQss-s0ymljUO_HbLAEd6Mxj3heXCV1D1jroPFQXXTf4B231xDRP7XTuBMDI8U&amp;s=T-xth_ct0uienKuzBbaltXB2a337KMNgVr_ky20JQwk&amp;e=" target="_blank">Up to Date</a>" as having received all recommended doses in the primary series COVID-19 vaccine, and a&nbsp;<a rel="noreferrer noopener" href="https://urldefense.proofpoint.com/v2/url?u=https-3A__www.cdc.gov_coronavirus_2019-2Dncov_vaccines_booster-2Dshot.html&amp;d=DwMFaQ&amp;c=HewDBbpecYK86KWBb8Fx0DnzxvObmqf6JAhppYEfnqk&amp;r=fXtlqKoFMPH8BEmgo44GULB-Np4fdjnHiYeVS0t1RrvoyCPiOw1ENvUjbQ6fhG5R&amp;m=YsuQss-s0ymljUO_HbLAEd6Mxj3heXCV1D1jroPFQXXTf4B231xDRP7XTuBMDI8U&amp;s=e-zs3l_0zxmRB8Sh4HC9t_UTnIMMa5ppPMf6IMZ7-vY&amp;e=" target="_blank">booster dose</a>&nbsp;when eligible.* In addition, participants must have a negative result from a PCR test taken up to 48 hours prior to arrival at event registration.&nbsp;All participants will show proof of "Up to Date" vaccination status and the negative PCR test before receiving event credentials. Mask&nbsp;protocols will be shared prior to the event and will be based on local guidelines.



*Those who have not received their booster dose will be tested on-site daily.&nbsp;

Join the Brainstorm Health community-- a powerful gathering of leaders at the crossroads of business, health care, technology, and innovation.

Bristol

salesforce

Stanford

Thrive

FORTUNE Brainstorm Health 2022

Ritz Carlton Marina Del Rey 4375 Admiralty Way Marina del Rey, California 90292 United States
Five miles from LAX airport, near Venice Beach and Santa Monica, <a href="https://www.ritzcarlton.com/en/hotels/california/marina-del-rey/hotel-overview" target="_blank" rel="noopener">The Ritz-Carlton, Marina del Rey</a> offers five-star luxury with a distinctly Californian touch.
<img class="alignnone size-full wp-image-1953" title="Default" src="https://content.fortuneconferences.com/wp-content/uploads/2022/02/Ritz-Marina-Del-Ray-Exterior.jpeg" alt="" width="488" height="251" />

Agenda